Zacks Investment Management Adaptive Biotechnologies Corp Transaction History

Zacks Investment Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $30,638 - $39,712	3,928 Added 4.81%	85,627 $756,000
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $80,165 - $119,608	-12,806 Reduced 13.55%	81,699 $624,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $614,282 - $1.2 Million	94,505 New	94,505 $673,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.